title: Flawed invisible trial underpins US morning sickness drug, researchers say.
authors.forename: Owen
authors.initials: O
authors.lastname: Dyer
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards*; D004025:Dicyclomine / Q000627:therapeutic use*; D004319:Doxylamine / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D005260:Female; D006801:Humans; D048968:Morning Sickness / Q000188:drug therapy*; D011247:Pregnancy; D011736:Pyridoxine / Q000627:therapeutic use*
chemical_list: D000932:Antiemetics; D004338:Drug Combinations; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine